New RSV vaccine shows promise for High-Risk younger adults
NCT ID NCT06389487
First seen Nov 01, 2025 · Last updated May 13, 2026 · Updated 28 times
Summary
This study tested an experimental RSV vaccine in adults aged 18-49 who are at increased risk for RSV disease, comparing their immune response and safety to adults aged 60 and older. Around 1,459 participants took part. The goal was to see if the vaccine works as well in younger high-risk adults as it does in older adults.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RESPIRATORY SYNCYTIAL VIRUS INFECTIONS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
GSK Investigational Site
Glendale, Arizona, 85308, United States
-
GSK Investigational Site
Phoenix, Arizona, 85284, United States
-
GSK Investigational Site
North Hollywood, California, 91606-3287, United States
-
GSK Investigational Site
Oakland, California, 94610, United States
-
GSK Investigational Site
Walnut Creek, California, 94598, United States
-
GSK Investigational Site
Hialeah, Florida, 33012, United States
-
GSK Investigational Site
North Miami, Florida, 33173, United States
-
GSK Investigational Site
Orlando, Florida, 32806, United States
-
GSK Investigational Site
Lexington, Kentucky, 40509, United States
-
GSK Investigational Site
Silver Spring, Maryland, 20904, United States
-
GSK Investigational Site
Rochester, New York, 14609, United States
-
GSK Investigational Site
Oklahoma City, Oklahoma, 73111, United States
-
GSK Investigational Site
Knoxville, Tennessee, 37909, United States
-
GSK Investigational Site
DeSoto, Texas, 75115, United States
-
GSK Investigational Site
Charlottesville, Virginia, 22911, United States
-
GSK Investigational Site
Wenatchee, Washington, 98801, United States
-
GSK Investigational Site
Coffs Harbour, New South Wales, 2450, Australia
-
GSK Investigational Site
Sydney, New South Wales, 2010, Australia
-
GSK Investigational Site
Sydney, New South Wales, 2065, Australia
-
GSK Investigational Site
Fortitude Valley, Queensland, 4006, Australia
-
GSK Investigational Site
Tarragindi, Queensland, 4121, Australia
-
GSK Investigational Site
Melbourne, Victoria, 3051, Australia
-
GSK Investigational Site
St Albans, Victoria, 3021, Australia
-
GSK Investigational Site
New Westminster, British Columbia, V3L 3W4, Canada
-
GSK Investigational Site
Victoria, British Columbia, V8V 4A1, Canada
-
GSK Investigational Site
Truro, Nova Scotia, B2N 1L2, Canada
-
GSK Investigational Site
Greater Sudbury, Ontario, P3C 1X3, Canada
-
GSK Investigational Site
Guelph, Ontario, N1G 0B4, Canada
-
GSK Investigational Site
London-Ontario, Ontario, N5W 6A2, Canada
-
GSK Investigational Site
Toronto, Ontario, M4G 3E8, Canada
-
GSK Investigational Site
Québec, Quebec, G1N 4V3, Canada
-
GSK Investigational Site
Québec, Quebec, G1V 4G2, Canada
-
GSK Investigational Site
Québec, Quebec, G1V 4W2, Canada
-
GSK Investigational Site
Saint-Charles-Borromée, Quebec, J6E 2B4, Canada
-
GSK Investigational Site
Sherbrooke, Quebec, J1J 2G2, Canada
-
GSK Investigational Site
Weinheim, Baden-Wurttemberg, 69469, Germany
-
GSK Investigational Site
Berlin, 10117, Germany
-
GSK Investigational Site
Berlin, 10787, Germany
-
GSK Investigational Site
Berlin, 13347, Germany
-
GSK Investigational Site
Essen, 45355, Germany
-
GSK Investigational Site
Mainz, 55116, Germany
-
GSK Investigational Site
Wallerfing, 94574, Germany
-
GSK Investigational Site
Witten, 58455, Germany
-
GSK Investigational Site
Würzburg, 97070, Germany
-
GSK Investigational Site
Ibaraki, 300-0062, Japan
-
GSK Investigational Site
Kanagawa, 211-0041, Japan
-
GSK Investigational Site
Tokyo, 155-0031, Japan
-
GSK Investigational Site
Tokyo, 180-0022, Japan
-
GSK Investigational Site
Cape Town, 7530, South Africa
-
GSK Investigational Site
Cape Town, 7700, South Africa
-
GSK Investigational Site
Johannesburg, 2113, South Africa
-
GSK Investigational Site
Reiger Park, 1459, South Africa
Conditions
Explore the condition pages connected to this study.